Validation of a novel risk score for severity of illness in acute exacerbations of COPD

Chest

Volumn 140, Issue 5, 2011, Pages 1177-1183

  Shorr, Andrew F ^a   Sun, Xiaowu ^b   Johannes, Richard S ^b,c   Yaitanes, Ayla ^b   Tabak, Ying P ^b  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b Department of Clinical Research   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ACUTE RESPIRATORY FAILURE; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; ARTIFICIAL VENTILATION; BAP 65 SYSTEM; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HOSPITAL; HOSPITAL ADMISSION; HOSPITAL COST; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MORTALITY; PRIORITY JOURNAL; PULSE RATE; SCORING SYSTEM; UNITED STATES; UREA NITROGEN BLOOD LEVEL; VALIDATION PROCESS;

EID: 81055145177     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-3035     Document Type: Article

References (14)

1. Trends in COPD (chronic bronchitis and emphysema): morbidity and mortality. American Lung Association Web site. http://www.lungusa.org/finding- cures/our-research/trend-reports/copd-trend-report.pdf. Accessed May 19, 2010.
2. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. MMWR Surveill Summ. 2002;51(6):1-16.
3. Quon BS, Gan WQ, Sin DD. Contemporary management of acute exacerbations of COPD: a systematic review and metaanalysis. Chest. 2008;133(3):756-766. (Pubitemid 351367386)
4. Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest. 2000;117(suppl 2):5S-9S. (Pubitemid 30111556)
5. Rabe KF, Hurd S, Anzueto A, et al. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532-555. (Pubitemid 47403272)
6. Hurst JR, Vestbo J, Anzueto A, et al.; Evaluation of COPD Longitudinally to Identify Predictive Surrogate End points (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128-1138.
7. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336(4):243-250. (Pubitemid 27044625)
8. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377-382. (Pubitemid 36560938)
9. Aujesky D, Obrosky DS, Stone RA, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med. 2005;172(8):1041-1046. (Pubitemid 41476544)
10. Sanchez O, Trinquart L, Caille V, et al. Prognostic factors for pulmonary embolism: the prep study, a prospective multicenter cohort study. Am J Respir Crit Care Med. 2010;181(2):168-173.
11. Tabak YP, Sun X, Johannes RS, Gupta V, Shorr AF. Mortality and need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: development and validation of a simple risk score. Arch Intern Med. 2009;169(17):1595-1602.
12. Roche N, Zureik M, Soussan D, Neukirch F, Perrotin D; Urgence BPCO (COPD Emergency) Scientific Committee. Predictors of outcomes in COPD exacerbation cases presenting to the emergency department. Eur Respir J. 2008;32(4):953-961.
13. The COPD population. Agency for Healthcare Research and Quality Web site. http://hcupnet.ahrq.gov/HCUPnet.jsp?Id=7A7823A46C5E3D89&Form= SelDXPR&JS=Y&Action=%3E%3ENext%3E%3E&-DXPR=DCCHPR1. Accessed November 5, 2010.
14. Lindenauer PK, Pekow P, Gao S, Crawford AS, Gutierrez B, Benjamin EM. Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 2006;144(12):894-903. (Pubitemid 46768129)